tu to publikāciju arī lasīji kaut mazliet?

TAVS VARIANTS:
"Meta-analysis of 15 trials ... found that ivermectin prophylaxis reduced COVID-19 infection by an average 86%."

REĀLĀ PUBLIKĀCIJA:
Three studies involving 738 participants evaluated ivermectin for COVID-19 prophylaxis among health care workers and COVID-19 contacts. Meta-analysis of these 3 trials, assessing 738 participants, found that ivermectin prophylaxis among health care workers and COVID-19 contacts probably reduces the risk of COVID-19 infection by an average of 86% (79%–91%) (3 trials, 738 participants; aRR 0.14, 95% CI 0.09–0.21; 5.0% vs. 29.6% contracted COVID-19, respectively; low-certainty evidence; downgraded due to study design limitations and few included trials

atrodi dažas atšķirības ;]